Related Experiment Video
Updated: Jun 25, 2025

Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling
Published on: April 7, 2015
Peri-Myocarditis as a Dire Consequence of Coronavirus Disease: A Clinical Challenge
Ramya Pakala1, Niyati Grewal1, Jin Yi2
1Internal Medicine, Howard University Hospital, Washington, USA.
Insights
Fulminant myocarditis, a severe heart inflammation, can rapidly develop in patients with Coronavirus disease 2019 (COVID-19). This case highlights unique challenges in diagnosing and managing this aggressive cardiac condition, emphasizing the need for vigilance.
Area of Science:
- Cardiology
- Infectious Diseases
- Pathology
Background:
- Myocarditis involves heart muscle inflammation, often triggered by viral infections, medications, or systemic inflammatory issues.
- Coronavirus disease 2019 (COVID-19) is caused by the SARS-CoV-2 virus.
- Fulminant myocarditis is a severe, rapidly progressing form of myocarditis leading to significant cardiac dysfunction.
Observation:
- This report details a specific case of fulminant myocarditis occurring in a patient diagnosed with COVID-19.
- The case presented a distinct timeline, progression pattern, and diagnostic/management complexities.
Findings:
- COVID-19 infection was identified as the cause of fulminant myocarditis in this patient.
- The unique characteristics of this case underscore the variability in disease presentation and progression.
Implications:
- Healthcare providers must maintain heightened awareness for fulminant myocarditis in COVID-19 patients.
- Early recognition and proactive management are crucial due to the potential for rapid cardiac impairment.
- This case contributes to understanding the spectrum of cardiovascular complications associated with SARS-CoV-2 infection.
Abstract:
Myocarditis is an inflammation of the heart muscle, most commonly caused by viral infections, with other contributing factors including medications or systemic inflammatory conditions. Coronavirus disease 2019 (COVID-19) is a disease caused by the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2 virus). In this report, we present a case of fulminant myocarditis in a patient with COVID-19 infection. Fulminant myocarditis is an aggressively progressive and severe variant that can result in substantial cardiac impairment. We present a case of fulminant myocarditis with a unique time course, progression, and potential challenges faced in diagnosis and management. Healthcare providers need to remain vigilant and anticipate the potential rapid progression of this disease.
More Related Videos
Related Concept Videos
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Pneumonia III: Complications and Assessment
Pneumonia II: Pathophysiology
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Acute Pharyngitis
Acute pharyngitis is the inflammation of the back of the throat (pharynx), commonly resulting in a sore throat. It is a frequently encountered condition that prompts individuals to seek medical advice.
Classification
Acute pharyngitis can be categorized based on its underlying cause:
Acute Respiratory Failure-I
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...

